Testosterone Research Brings New Hope for Cancer Patients

Testosterone Research Brings New Hope for Cancer Patients – an article from Science Daily.

This is certainly not the first article published on the benefits of anabolic steroids for cancer cachexia. Anabolic steroids, such as testosterone and nandrolone, not only reduce muscle wasting, they also increase erythropoietin release, thereby mitigating the anemia and fatigue associated with maximum tolerated dose regimens. This affords the patients less transfusions, as well as a decreased need for erythropoietin stimulating agents, which have shown to increase mortality in cancer patients.

Commonly recommended drugs for appetite stimulation, such as progestins, corticosteroids, and dronabinol, are minimally and transiently effective. In addition, there is no risk of promoting the aggressiveness of the cancer with anabolic steroids if the cancer does not possess androgen receptors. To the contrary, breast cancer survivors who received subcutaneous implants containing testosterone in combination with a low dose of anastrozole for relief of menopausal symptoms, have had no recurrence of cancer after eight years of testosterone therapy.
Bottom line: consider the use of anabolic steroids for cancer cachexia, as long as the cancer does not possess androgen receptors, such as prostate cancer and often triple negative breast cancer.

healthyliving June 20th, 2019

Posted In: cancer care

Tags: anabolic steroids, cancer, cancer cachexia, cancer care, nandrolone, testosterone